MFGE8 and breast neoplasm: We injected 2.0 × 106 highly metastatic MDA-MB-231 breast tumor cells on day 0 and, on the same day, treated mice with either sEV-MDA231 (10 μg total protein) or lactadherin-blocked sEV-MDA231 (Fig. 8A).